Category: Drug supply chain

For many patients relying on it for glaucoma treatment, dorzolamide has been subject to frustrating and sudden shortages in recent years. These supply chain disruptions, impacting a widely used generic drug, highlight a fragile pharmaceutical ecosystem. A complex mix of economic pressures, manufacturing challenges, and market forces makes it hard to get dorzolamide, putting patient care at risk.